🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to assess the pharmacokinetics (PK) and safety of SC pembroli...
Status
Active Not Recruiting
Location
Fujita Health University ( Site 4406)
Start Date
2023-06-13
Trial ID
NCT06212752
This is a phase 3, randomized, double-blind study of adjuvant calderasib pl...
Status
Recruiting
Location
Instituto Alexander Fleming ( Site 0310)
Start Date
2026-03-18
Trial ID
NCT07431827
Treatments Being Tested
Researchers are looking for new ways to treat non-small cell lung cancer (N...
Status
Active Not Recruiting
Location
Providence Medical Foundation ( Site 0117)
Start Date
2024-11-21
Trial ID
NCT06698042
Treatments Being Tested
The purpose of this study is to evaluate participant preference for coformu...
Status
Active Not Recruiting
Location
Russell Medical ( Site 0160)
Start Date
2023-12-26
Trial ID
NCT06099782
Treatments Being Tested
The primary objective of this study is to evaluate the effectiveness of zan...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-06
Trial ID
NCT07750158
Treatments Being Tested
This study is to assess the pharmacokinetics (PK) and safety of SC pembroli...
Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center-Dignity Health Cancer Institute ( Site 0023)
Start Date
2023-02-14
Trial ID
NCT05722015
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Active Not Recruiting
Location
Nagoya University Hospital ( Site 0003)
Start Date
2023-10-20
Trial ID
NCT06041802
Treatments Being Tested
Researchers are looking for new ways to treat high-risk, localized non-smal...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center ( Site 3204)
Start Date
2026-05-04
Trial ID
NCT07513376
Treatments Being Tested
The primary purpose of the study is to assess the pharmacokinetics (PK) pro...
Status
Active Not Recruiting
Location
University of Iowa-Holden Comprehensive Cancer Center ( Site 0115)
Start Date
2024-10-14
Trial ID
NCT06504394
Treatments Being Tested
Researchers want to learn if the study medicines calderasib and subcutaneou...
Status
Recruiting
Location
Central Alabama Research ( Site 0108)
Start Date
2025-10-08
Trial ID
NCT07190248
Treatments Being Tested